Latest Breaking News On - அந்தோணி மார்சியானோ - Page 5 : comparemela.com

Seelos Therapeutics Announces Proposed Public Offering of Common Stock News provided by Share this article Share this article NEW YORK, May 19, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) disorders and rare diseases, announced today that it has commenced an underwritten public offering of shares of common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the aggregate number of shares of common stock sold in the offering on the same terms and conditions. All of the shares of common stock in the offering will be sold by Seelos.

New yorkUnited statesAnthony marcianoExchange commissionEquity syndicate departmentPrnewswire seelos therapeutics incSeelos therapeutics incHead of corporate communicationsGuggenheim securitiesSeelos therapeuticsAcute suicidal ideationMajor depressive disorderPost traumatic stress disorderLooking statementsPrivate securities litigation reform actSeelo annual report